First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors ; volume:8 ; number:1 ; day:12 ; month:9 ; year:2024 ; pages:1-9 ; date:12.2024
npj precision oncology ; 8, Heft 1 (12.9.2024), 1-9, 12.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Zhang, Jian
Du, Yiqun
Meng, Yanchun
Liu, Xiaojun
Mu, Yuxin
Liu, Yunpeng
Shi, Yehui
Wang, Jufeng
Zang, Aimin
Gu, Shanzhi
Liu, Tianshu
Zhou, Huan
Guo, Hongqian
Xiang, Silong
Zhang, Xialu
Wu, Suqiong
Qi, Huanhuan
Li, Mengke
Hu, Xichun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-024-00687-7
- URN
-
urn:nbn:de:101:1-2411262110476.201698309400
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Jian
- Du, Yiqun
- Meng, Yanchun
- Liu, Xiaojun
- Mu, Yuxin
- Liu, Yunpeng
- Shi, Yehui
- Wang, Jufeng
- Zang, Aimin
- Gu, Shanzhi
- Liu, Tianshu
- Zhou, Huan
- Guo, Hongqian
- Xiang, Silong
- Zhang, Xialu
- Wu, Suqiong
- Qi, Huanhuan
- Li, Mengke
- Hu, Xichun
- SpringerLink (Online service)
Ähnliche Objekte (12)
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Supervision method of indoor construction engineering quality acceptance based on cloud computing
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
Combined therapy of dabrafenib and an anti-HER2 antibody–drug conjugate for advanced BRAF-mutant melanoma
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer
Optimierung der Chemikaliendosierung in Anlagen zur Wasseraufbereitung mit Hilfe eines kontinuierlichen Flockungstestgerätes
W. H. Auden’s anti-Japanese war: “Sonnets from China” and its historical context
Synthesis and fluorescence of pyrazolines substituted with pyrimidine and ferrocene subunits
Blow-up solutions with minimal mass for nonlinear Schrödinger equation with variable potential
Implementation of Pedestrian Path Navigation Algorithm Based on "We-Map" Platform
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Supervision method of indoor construction engineering quality acceptance based on cloud computing
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
Combined therapy of dabrafenib and an anti-HER2 antibody–drug conjugate for advanced BRAF-mutant melanoma
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer
Optimierung der Chemikaliendosierung in Anlagen zur Wasseraufbereitung mit Hilfe eines kontinuierlichen Flockungstestgerätes
W. H. Auden’s anti-Japanese war: “Sonnets from China” and its historical context
Synthesis and fluorescence of pyrazolines substituted with pyrimidine and ferrocene subunits
Blow-up solutions with minimal mass for nonlinear Schrödinger equation with variable potential
Implementation of Pedestrian Path Navigation Algorithm Based on "We-Map" Platform
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Supervision method of indoor construction engineering quality acceptance based on cloud computing
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
Combined therapy of dabrafenib and an anti-HER2 antibody–drug conjugate for advanced BRAF-mutant melanoma
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer
Optimierung der Chemikaliendosierung in Anlagen zur Wasseraufbereitung mit Hilfe eines kontinuierlichen Flockungstestgerätes
W. H. Auden’s anti-Japanese war: “Sonnets from China” and its historical context
Synthesis and fluorescence of pyrazolines substituted with pyrimidine and ferrocene subunits
Blow-up solutions with minimal mass for nonlinear Schrödinger equation with variable potential
Implementation of Pedestrian Path Navigation Algorithm Based on "We-Map" Platform